scholarly article | Q13442814 |
P2093 | author name string | S L Seneviratne | |
R de Silva | |||
L V Gooneratne | |||
M N Tudawe | |||
C N Wijeyaratne | |||
D Ratnayake | |||
Dbia Jayawardane | |||
E Palipane | |||
S H Dodampahala | |||
Sla Galappaththi | |||
P2860 | cites work | Aspirin and/or heparin for women with unexplained recurrent miscarriage with or without inherited thrombophilia | Q24194917 |
Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials | Q28192029 | ||
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
Primary antiphospholipid syndrome in Latin American mestizo patients: clinical and immunologic characteristics and comparison with European patients | Q33378048 | ||
Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin | Q33378067 | ||
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
Antiphospholipid syndrome: obstetric diagnosis, management, and controversies | Q35150503 | ||
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) | Q36242479 | ||
Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism | Q37088895 | ||
Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss--a review of literature of various therapeutic protocols | Q37519788 | ||
Diagnosis and management of the antiphospholipid syndrome | Q37753513 | ||
Association of anticardiolipin antibodies with preeclampsia: a systematic review and meta-analysis | Q37811769 | ||
SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. | Q43125859 | ||
Primary antiphospholipid syndrome: pregnancy outcome in a portuguese population | Q43263630 | ||
Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin | Q47868175 | ||
Antiphospholipid antibodies in pregnancy | Q47873939 | ||
Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure | Q57523494 | ||
Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol | Q59552940 | ||
Antiphospholipid antibodies | Q68495887 | ||
Thrombocytopenia in the antiphospholipid syndrome | Q73306638 | ||
The antiphospholipid syndrome | Q77739053 | ||
P433 | issue | 2 | |
P921 | main subject | antiphospholipid syndrome | Q582207 |
P304 | page(s) | 83-89 | |
P577 | publication date | 2016-03-17 | |
P1433 | published in | Obstetric medicine | Q26842307 |
P1476 | title | Pregnancy outcomes of antiphospholipid syndrome: In a low resource South Asian setting | |
P478 | volume | 9 |
Search more.